Healthcare stocks were higher late Friday afternoon, with the NYSE Healthcare Index rising 0.8% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.6%.
The iShares Biotechnology ETF (IBB) was easing 0.2%.
In corporate news, AstraZeneca (AZN) has eliminated around 600 positions in its respiratory and immunology commercial teams in the US as part of its three-year program to cut costs and reallocate resources to developing new drugs, Bloomberg reported. AstraZeneca shares were up 0.3%.
Windward Bio (WWB) shares surged 72% in their Nasdaq debut on Friday after the clinical-stage biotechnology company sold 10.3 million shares at $17 apiece in its initial public offering.
NeuroPace (NPCE) shares fell 44% after it reduced its full-year revenue outlook as Q3 sales lagged market expectations, according to results posted late Thursday.
SBC Medical Group (SBC) shares jumped 31% after it said it has made a minority equity investment in Taiwan-based NeuroBrain Dynamics and agreed to jointly develop six medical AI tools for its clinic network.
Tandem Diabetes Care (TNDM) shares rose nearly 15% after the company said it obtained clearance from the US Food and Drug Administration for its automated insulin delivery system, Tandem Mobi, to be used with a tubeless cartridge and infusion set.
Comments